Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection
NCT ID: NCT01308424
Last Updated: 2013-08-13
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE1/PHASE2
171 participants
INTERVENTIONAL
2011-01-31
2012-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
BTL TML HSV
BTL TML HSV
Sublingual micro-dosing for 7 days
Matching Placebo
Matching placebo
sublingual dosing for 7 days
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
BTL TML HSV
Sublingual micro-dosing for 7 days
Matching placebo
sublingual dosing for 7 days
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Experiences prodromal symptoms (tingling, burning, itching) of cold sores
* Herpes Simplex Virus seropositive (by blood test)
Exclusion Criteria
* Use of antiviral therapy directly prior and during the study
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Beech Tree Labs, Inc.
INDUSTRY
Norwich Clinical Research Associates Ltd.
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Kentucky College of Dentistry/Center for Oral Health Research
Lexington, Kentucky, United States
School of Dental Medicine, University at Buffalo
Buffalo, New York, United States
Family Dentistry
Norwich, New York, United States
University of Pittsburgh School of Dental Medicine
Pittsburgh, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Mamber SW, Hatch T, Miller CS, Murray JV, Strout C, McMichael J. Low-dose Oral Thimerosal for the Treatment of Oral Herpes: Clinical Trial Results and Improved Outcome After Post-hoc Analysis. J Evid Based Integr Med. 2022 Jan-Dec;27:2515690X221078004. doi: 10.1177/2515690X221078004.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2010-03-0112
Identifier Type: -
Identifier Source: org_study_id